124 related articles for article (PubMed ID: 17089576)
1. Comparison of GnRH antagonist cycles with and without oral contraceptive pretreatment in potential poor prognosis patients.
Bendikson K; Milki AA; Speck-Zulak A; Westphal LM
Clin Exp Obstet Gynecol; 2006; 33(3):145-7. PubMed ID: 17089576
[TBL] [Abstract][Full Text] [Related]
2. The effect of oral contraceptive pill for cycle scheduling prior to GnRH-antagonist protocol on IVF cycle parameters and pregnancy outcome.
Pinkas H; Sapir O; Avrech OM; Ben-Haroush A; Ashkenzi J; Fisch B; Farhi J
J Assist Reprod Genet; 2008 Jan; 25(1):29-33. PubMed ID: 18205037
[TBL] [Abstract][Full Text] [Related]
3. Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.
Kim CH; Jeon GH; Cheon YP; Jeon I; Kim SH; Chae HD; Kang BM
Fertil Steril; 2009 Nov; 92(5):1758-60. PubMed ID: 19523618
[TBL] [Abstract][Full Text] [Related]
4. To pill or not to pill in GnRH antagonist cycles: that is the question!
Garcia-Velasco JA; Fatemi HM
Reprod Biomed Online; 2015 Jan; 30(1):39-42. PubMed ID: 25447926
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis.
Griesinger G; Venetis CA; Marx T; Diedrich K; Tarlatzis BC; Kolibianakis EM
Fertil Steril; 2008 Oct; 90(4):1055-63. PubMed ID: 18054003
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial.
Kolibianakis EM; Papanikolaou EG; Camus M; Tournaye H; Van Steirteghem AC; Devroey P
Hum Reprod; 2006 Feb; 21(2):352-7. PubMed ID: 16269449
[TBL] [Abstract][Full Text] [Related]
8. Effect of a low dose combined oral contraceptive pill on the hormonal profile and cycle outcome following COS with a GnRH antagonist protocol in women over 35 years old.
Bakas P; Hassiakos D; Grigoriadis C; Vlahos NF; Liapis A; Creatsas G
Gynecol Endocrinol; 2014 Nov; 30(11):825-9. PubMed ID: 24954511
[TBL] [Abstract][Full Text] [Related]
9. Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.
Lainas TG; Sfontouris IA; Venetis CA; Lainas GT; Zorzovilis IZ; Tarlatzis BC; Kolibianakis EM
Hum Reprod; 2015 Oct; 30(10):2321-30. PubMed ID: 26307091
[TBL] [Abstract][Full Text] [Related]
10. Ganirelix acetate use in normal- and poor-prognosis patients and the impact of estradiol patterns.
Shapiro DB; Mitchell-Leef D; Carter M; Nagy ZP
Fertil Steril; 2005 Mar; 83(3):666-70. PubMed ID: 15749496
[TBL] [Abstract][Full Text] [Related]
11. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
[TBL] [Abstract][Full Text] [Related]
12. Effects of oral contraceptive for different responder women before GnRH antagonists: a systematic review and meta-analysis.
Li J; Sun Y; Mo S; Wang S; Luo W
Gynecol Endocrinol; 2021 Nov; 37(11):977-986. PubMed ID: 33975507
[TBL] [Abstract][Full Text] [Related]
13. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
[TBL] [Abstract][Full Text] [Related]
14. Modified natural cycle using GnRH antagonist can be an optional treatment in poor responders undergoing IVF.
Elizur SE; Aslan D; Shulman A; Weisz B; Bider D; Dor J
J Assist Reprod Genet; 2005 Feb; 22(2):75-9. PubMed ID: 15844732
[TBL] [Abstract][Full Text] [Related]
15. Dual suppression with oral contraceptive pills in GnRH antagonist cycles for patients with polycystic ovary syndrome undergoing intracytoplasmic sperm injection.
Ozmen B; Sükür YE; Seval MM; Ateş C; Atabekoğlu CS; Sönmezer M; Berker B
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():137-40. PubMed ID: 25461367
[TBL] [Abstract][Full Text] [Related]
16. Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill?
Elassar A; Nulsen J; Engmann L; Benadiva C
J Reprod Med; 2015; 60(5-6):199-204. PubMed ID: 26126304
[TBL] [Abstract][Full Text] [Related]
17. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
18. Oral contraceptive pill, progestogen or estrogen pre-treatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Smulders B; van Oirschot SM; Farquhar C; Rombauts L; Kremer JA
Cochrane Database Syst Rev; 2010 Jan; (1):CD006109. PubMed ID: 20091585
[TBL] [Abstract][Full Text] [Related]
19. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
[TBL] [Abstract][Full Text] [Related]
20. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
